Exclusive: GW Pharmaceuticals Hires Investment Bank Following Approaches – Sources

By:
Exclusive: GW Pharmaceuticals Hires Investment Bank Following Approaches - Sources

Flickr / CC BY-SA 2.0 / Flazingo Photos

GW Pharmaceuticals Plc (Nasdaq:GWPH), a developer of marijuana-based epilepsy treatments, is working with an investment bank after other drugmakers approached it to express interest in an acquisition, people familiar with the matter said.

The move shows how the Cambridge, England-based company is emerging as a coveted target for larger pharmaceutical companies thanks to its key drug, Epidiolex, which uses cannabis-based compounds to treat epilepsy.

View Original Article Here

Repost is the designation for articles collected from the Internet whose content may interest our readers. These articles are not written by our staff and they do not necessarily reflect our views.

Related posts

Top